Expert Opinion

"At the moment, those undergoing the treatment are between 16 and 53. On average, after only 10 sessions, not only is there great improvement in vision but it is also maintained for at least two years."

Prof Donald Tan, Director Singapore Eye Research Institute and Deputy Director, Singapore National Eye Centre

"This treatment helps the brain to better understand the images the eyes are sending it, rather than altering the images the eyes receive by using corrective lenses or surgically altering the eye itself."

Dr Chan Wing Kwong, Senior Consultant and Head of Refractive Surgery Centre, Singapore National Eye Centre

"For example, select an item in your house that you cannot see clearly. After that, every five sessions, take a look at the object again and you will notice that your vision has become sharper. These are testimonials from patients who have experienced this."

Prof Donald Tan, Director Singapore Eye Research Institute and Deputy Director, Singapore National Eye Centre

"Vision is dependent on two things, how your eye receives the image and how your brain interprets the image. NeuroVision helps the brain to interpret sharper images."

Dr Chan Wing Kwong, Senior Consultant and Head of Refractive Surgery Centre, Singapore National Eye Centre

"Naturally we were quite skeptical about the whole thing, because traditionally, ophthalmologists thought that apart from glasses and surgery, other methods wouldn't work for myopia. But we tried it out, and it did work."

Dr Chan Wing Kwong, Senior Consultant and Head of Refractive Surgery Centre, Singapore National Eye Centre

NeuroVision™'s innovative technology is the result of 20 years of intensive scientific and clinical research in understanding how the brain processes visual information, how neural activity is related to visual perception and how visual processing interacts with other neural systems. NeuroVision™ technology is a non-invasive, patient-specific vision perceptual learning program based on visual stimulation and facilitation of neural connection responsible for vision. It facilitates neural connections at the cortical level through a computerized visual training regimen using Gabor Patches to improve contrast sensitivity and visual acuity by reducing the noise-to signal ratio of neural activity in the primary visual cortex.

It is implemented as an interactive computerized training regimen using various parameters of the visual stimulus (Gabor Patches) delivered to customers in the comfort of their homes or at clinics, using a standard PC connected to the Internet.

The technology has been clinically proven in the treatment of adult amblyopia ("lazy eye"), which until now has been considered untreatable and has received FDA 510(k) marketing clearance indicating NVC for the treatment of adult amblyopia in patients 9 years or older. It also received Medical CE-Mark to market its products in the EU.